In this episode of the Data and Biotech Podcast, host Ross Katz sits down with Alexander Junge, Co-Founder and CTO of amass, to break down how AI is reshaping scientific research in life sciences.

Alex walks us through how his platform is creating professional tools for researchers, biotech companies, and venture firms to navigate the (rapidly!) growing breadth and depth of scientific knowledge by leveraging artificial intelligence - and what this will look like in the future.

Alex also shares insights into his company’s work with Nordic Bio Ventures and how amass delivers reliability and builds trust in its platform.

What You'll Learn in This Episode:

What challenges researchers face in formulating questions and retrieving relevant answers from the breadth of scientific knowledge.
The importance of design and user experience in life sciences, and how the company adopts a rigorous approach to information retrieval.
How amass helps life sciences professionals navigate complex scientific domains by building trust in answers generated by AI.
A real-world case study of how amass is assisting Nordic BioVentures a venture firm to build a biotech company.
Alex’s predictions for AI's impact on scientific discovery over the next decade.

Connect with Our Guest:

Sponsor: CorrDyn, a data consultancy
Find out more about amass
Connect with Alex on LinkedIn

Connect with Us:

Follow the podcast for more insightful discussions on the latest in biotech and data science.
Subscribe and leave a review if you enjoyed this episode!

157 | David Kilgore, On & Red Bull Athlete